Terumo Announces First Clinical Case of a CE Certified Precision-Drive Articulating Surgical System

By Terumo Cardiovascular Systems Corporation, PRNE
Wednesday, May 11, 2011

LEUVEN, Belgium, May 12, 2011 - Terumo Europe N.V. announced today that the first operation with the CE
certified Kymerax(TM) System was successfully performed in Europe. The
Kymerax(TM), a precision-drive articulating surgical system with indications
for use in endoscopic surgery, is a true innovation in the field of minimally
invasive surgery. Kymerax(TM) technology provides the surgeon with a
motor-driven, hand-held device with articulation at the instrument tip.

The first clinical procedure was performed by Prof. Dr. Gunter
, Director of the Department of Urology and Andrology at Paracelsus
Medical University, Salzburg, Austria in a urological case.

"I successfully finished the laparoscopic nephrectomy! It looks very
promising and I am convinced that this new technology will have an impact on
daily clinical use very quickly," said Prof. Janetschek.

About Kymerax(TM) System

The new technology, which recently received CE certification, shows
relevant differences in essential instrument components offering better
efficiency with a comparable safety profile. Operating with Kymerax(TM)
enables the surgeon to easily manipulate the handle's controls and buttons
and to effectively manoeuvre the instrument tip in multiple directions to
operate in areas that are difficult to approach.

"Surgeons routinely comment on the benefits of Kymerax(TM) in terms of
functional outcomes. They welcome the fact that they can operate close to the
patient and receive direct haptic feedback during laparoscopic procedure,"
said Mr. Masao Hitotsuyanagi, Terumo Business Unit Manager. With its
ergonomic design, Kymerax(TM) could also potentially mean less fatigue and
better manoeuvring for surgeons. Overall, Kymerax(TM) is suited for
laparoscopic procedures in gynecology, urology and gastrointestinal surgery
and provides another alternative approach to minimally invasive surgery. For
more information, visit www.kymerax.com.

About Terumo

Terumo Corporation is a premier global medical device company with annual
sales of more than 3.4 billion dollars for the fiscal year ending March 31,
. Founded in 1921, the company develops, manufactures and distributes
world-class medical devices, such as syringes, blood bags and IV solutions.
Terumo has the biggest share of the world markets for angiography guide wires
and perfusion products and is a leading developer of interventional products,
such as catheters and stents. For more information, visit

Brigitte Becker, European Marketing Manager, Advanced Surgical Systems, Terumo Europe N.V., +49-6196-8023-530, brigitte.becker at terumo-europe.com

Clinical Trials / Medical Discoveries News

May 12 News

will not be displayed